Cite
APA Citation
Lord, R., Burr, N., Mohammed, N., & Subramanian, V. (n.d.). pWE-035 HDCE using 0.03% versus 0.2% indigocarmine for detecting dysplasia in IBD colitis surveillance. RCT interim-analysis. Gut, 67, A84. http://access.bl.uk/ark:/81055/vdc_100144721896.0x000039